J9352 Trabectedin - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Trabectedin

Brand Name:

Yondelis

Strength:

0.1mg

HCPCS:

J9352

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Alkylating Agent

Minor Drug Class:

Natural Product

Oral (Y/N):

No

FDA Approval Year:

2015

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2017

CMS Discontinuation Date:

Status:

In Use